Gene Expression Market Report and Forecast 2025-2034

The global gene expression market attained a value of USD 13.30 Billion in 2024. The market is further expected to grow in the forecast period of 2025-2034 at a CAGR of 10.40%, to reach USD 35.77 Billion by 2034.

The gene expression market growth is driven by the rapid advancements in the field of genomics. In pharmaceutical companies, gene expression analysis is increasingly employed for drug discovery and development to accommodate the clinical needs of the growing patient population. On the other hand, biotechnology companies are actively investing in the market to develop novel therapies. Additionally, the rising prevalence of chronic diseases such as cancer and the substantial funding for genomic research is expected to accelerate the market growth in the forecast period.

Global Gene Expression Market Trends and Developments

Growing preference for personalized medicine, rising demand for precision oncology, expansion of RNA sequencing applications, and increasing use of gene expression research in infectious disease research comprise some of the key trends and developments in the market.

Growing Preference for Personalized Medicine

Gene expression analysis facilitates understanding of disease mechanisms and helps identify targeted therapies. The growing focus on personalized medicine, in which a specific treatment plan is designed based on the patient's genetic makeup, is elevating the gene expression market value.

Rising Demand for Precision Oncology

Gene expression analysis is increasingly used in oncology to identify molecular signatures of tumors. Thus, the advancement in genomics is fuelling a shift towards more precise and personalized cancer care.

Expansion of RNA Sequencing Applications

RNA sequencing (RNA-seq) is expanding beyond basic research into clinical applications, including disease diagnosis, treatment monitoring, and understanding of the immune response.

Increasing Use of Gene Expression in Infectious Disease Research

Gene expression profiling finds its application in infectious disease research such as the immune response to infections and identifying potential therapeutic targets for emerging pathogens. With the rising prevalence of infectious diseases and the growing demand for effective therapeutics, the market is expected to witness a surge.

August 2023

Almac Diagnostic Services (a member of the contract development and manufacturing organization Almac Group) expanded its NGS portfolio of DNA sequencing service offerings by investing in Illumina NovaSeq X Plus in its Ireland facility.

July 2023

Neoleukin Therapeutics, Inc., entered into a merger agreement with Neurogene Inc., a biotechnology company focused on the development of genetic medicines for rare neurological diseases. The merger is expected to strengthen the genetic drug pipeline of Neurogene Inc. and develop medications for rare diseases such as Rett Syndrome.

March 2023

Illumina Inc. launched its first whole genome sequencing (WGS) assay called ‘Illumina Complete Long Read Prep Human' that has been compatible with multiple sequencing systems. The product offers both long and short-read sequencing on the NovaSeq platform, along with simplified workflows and reduced DNA input requirements. Early customer data demonstrates high accuracy and flexibility, with the promotional price at USD 1,350 per whole genome.

March 2023

Chroma Medicine, Inc., secured USD 135 million in series B financing led by Google Ventures. The firm plans to use the investment to expand its precision genomic medicines portfolio and develop its epigenetic editing technology.

Global Gene Expression Market Demand

The market demand is propelled by the application of gene expression technologies across various domains from basic research to diagnostics and drug discovery. Heightened patient awareness and increased accessibility to healthcare services further bolster the market demand. The rising prevalence of genetic disorders has increased the focus on gene expression studies to identify potential therapeutic targets. With the data suggesting that 72% of rare diseases have a genetic origin, the gene expression market size is projected to expand in the forecast period.

Technological advancements such as the integration of artificial intelligence (AI) and machine learning in gene expression analysis are anticipated to contribute to market growth. Such innovations will simplify complex data and assist in predicting treatment outcomes, facilitating the utilization of gene expression profiles in clinical decision-making.

Global Gene Expression Market Segmentation

“Global Gene Expression Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Breakup by Products and Services

• Consumables
• Instruments
• Services

Breakup by Technology

• Polymerase Chain Reaction
• Next Generation Sequencing
• DNA Microarray
• Others

Breakup by Application

• Disease Diagnosis
• Drug Discovery
• Drug Development
• Others

Breakup by End User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institute
• Diagnostic and Clinical Laboratories
• Others

Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Gene Expression Market: Competitive Landscape

The key market players are contributing to the gene expression market growth through strategic mergers and acquisitions initiatives, novel product launches, and continuous research and development efforts aimed at providing improved patient solutions.

Other key players in the market include Revvity Inc., Agilent Technologies Inc., Oxford Nanopore Technologies Inc., PacBio, QIAGEN, Bio-Rad Laboratories Inc., Danaher Life Sciences, and Takara Bio Inc.

Global Gene Expression Market Analysis by Region

In North America, the market is witnessing significant growth which can be attributed to robust research and development efforts aimed at expanding the genomics field. Major funding from the public and private sectors also supports the ongoing gene expression studies. In addition, the presence of a well-established healthcare system and growing demand for targeted therapies is expected to boost the gene expression market size in the forecast period.

Asia Pacific is projected to experience rapid growth in the coming years supported by the rising disposable income and improvement of healthcare facilities. Moreover, the regional market offers lucrative growth opportunities for the key market players due to various factors such as the huge population base, rising prevalence of chronic diseases, and increased expenditure on healthcare services and products.

This product will be delivered within 3-5 business days.